Pharmaids Pharmaceuticals files complaint over ₹2.62 Cr cheque dishonour
- Pharmaids Pharmaceuticals filed complaints against Anugraha Chemicals for cheque dishonour
- Total claim amount is ₹2.62 crore comprising two cheques issued in July 2026
- Dispute stems from unpaid dues following Pharmaids' exit from partnership in the firm
- Legal action filed at Bengaluru court under Bharatiya Nagarik Suraksha Sanhita

*this image is generated using AI for illustrative purposes only.
Pharmaids Pharmaceuticals filed two complaints on September 15, 2026, against M/s Anugraha Chemicals and its partners for the dishonour of cheques totalling ₹2.62 crore. The legal action was initiated at the 34th Additional Chief Judicial Magistrate Court in Bengaluru under Section 223 of the Bharatiya Nagarik Suraksha Sanhita, 2023, read with Section 138 of the Negotiable Instruments Act, 1881.
The dispute arises from outstanding dues payable to Pharmaids following its exit from a partnership interest in Anugraha Chemicals. The payments were governed by a Disinvestment Agreement dated July 10, 2025, as modified by a Supplementary Agreement dated January 23, 2026.
Details of the Dishonoured Cheques
Anugraha Chemicals issued two cheques towards the discharge of the outstanding amount. Both instruments were returned unpaid on July 23, 2026, with the remark "Payment Stopped by the Drawer." Despite statutory demand notices issued by Pharmaids, the amount remains unpaid.
| Cheque Number | Amount (₹) | Status |
|---|---|---|
| 740165 | 52,50,000 | Dishonoured |
| 740166 | 2,10,00,000 | Dishonoured |
Parties Involved
The complaints name the following entities and individuals as respondents:
- M/s Anugraha Chemicals
- Mr. Sourabh S. Hadimani (Partner)
- Mrs. Sneha Hadimani (Partner)
Financial Implications
Pharmaids stated that there are no financial liabilities or implications for the company arising from this litigation, as it is the complainant seeking recovery of amounts due. The aggregate quantum of the claim is ₹2,62,50,000, exclusive of any compensation, interest, or costs that may be awarded by the court.
Historical Stock Returns for Pharmaids Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.55% | +0.13% | -5.72% | +8.96% | -49.29% | +111.58% |
How might this legal dispute impact the future strategic partnerships or joint ventures of Pharmaids Pharmaceuticals?
What are the potential liquidity implications for Anugraha Chemicals if the court enforces the payment of the ₹2.62 crore along with interest and costs?
Could this litigation serve as a precedent for how Pharmaids handles exit clauses in future disinvestment agreements?


































